If you’ve been looking into weight-loss medications, you’ve no doubt heard of Ozempic®, Wegovy®, and Mounjaro®. These GLP-1 receptor agonists are dominating headlines and transforming treatment for obesity and type 2 diabetes.
The problem? They can be incredibly expensive if you’re paying out of pocket. That’s led many people to seek affordable alternatives, including “GLP-1” patches.
We don’t believe in sacrificing safety for price, but that’s exactly what you’ll be doing if you choose GLP-1 patches.
GLP-1 patches do not actually contain semaglutide or tirzepatide or any other of the active ingredients found in GLP-1 medications, nor are they FDA approved or proven to be effective.
So, what are GLP-1 patches? Do they work? How do they compare to true GLP-1 medications?
🚨 Bottom Line
None of the ingredients commonly found in “GLP-1 patches” such as green tea extract, garcinia cambogia, guarana, bitter orange, berberine, and others have been proven to affect GLP-1 activity. Many of these compounds have been sold for decades in teas, powders, and pills with little to no meaningful impact on weight loss. Putting them into a patch does not make them more effective, and in most cases the skin can’t even absorb these ingredients properly.
The real concern I have is the marketing. By calling these products “GLP-1 patches,” companies create the illusion that they are linked to GLP-1 science. In reality, they contain no semaglutide, tirzepatide, or any other medication that is FDA-approved for weight loss. At best, you will experience the same minimal effects these supplements have always had. At worst, you waste money and experience unintended side effects.
The proven option: if you want safe and effective results, online GLP-1 clinics provide access to real medications prescribed by licensed providers. These programs are transparent, trustworthy, and focused on long-term success rather than marketing gimmicks.
See our full breakdown of the best online GLP-1 programs to understand your options.
- Clinically Proven: Real GLP-1 medications such as semaglutide and tirzepatide.
- Expert-Led Care: Licensed medical providers guide your treatment.
- Transparent Pricing: Clear costs with no tricks or hidden fees.
- Comprehensive Support: Medical guidance plus lifestyle and nutrition resources.
What Are GLP-1 Medications?

Since the 1980s, GLP-1 medications have been a sort of holy grail for pharmaceutical companies.[1] They knew if they could mimic the GLP-1 hormone, they could have a potential gamechanger for diabetes patients, but it took nearly three decades to perfect the process.
How GLP-1 Meds Became Popular
GLP-1s weren’t originally designed for weight loss. Drugs like Ozempic and Mounjaro were created and approved for type 2 diabetes management. But as patients began shedding significant pounds, researchers took notice.
FDA approvals for weight loss use followed. First Wegovy, then Zepbound. Celebrities and influencers started sharing their transformations. Meanwhile, demand surged in both medical and wellness circles. Today, GLP-1s are the most talked-about weight loss drugs in decades.
An astonishing one out of every eight American adults have tried them.[2]
How GLP-1s work
GLP-1 (glucagon-like peptide-1) medications mimic the action of your body’s natural GLP-1 hormone. Normally, GLP-1 is released from the gut after eating and signals the brain’s appetite-control centers while also slowing stomach emptying. By activating the same receptors, GLP-1 drugs enhance those fullness signals, so you feel satisfied sooner and with less food.[3]
GLP-1 drugs also slow down how quickly food leaves your stomach, which is known as gastric emptying. The more slowly food moves through your digestive tract, the smaller your appetite.
Finally, GLP-1s affect both insulin and glucagon release. GLP-1s cause your body to release more insulin, which lowers your blood sugar, and less glucagon, which raises your blood sugar.
For many patients, the result of these interactions is substantial weight loss.
Popular GLP-1 medications
Some of the most well-known GLP-1 drugs include:
- Semaglutide: Sold under the names Ozempic and Wegovy by manufacturer Novo Nordisk
- Tirzepatide: Technically a dual GLP-1/GIP agonist, sold as Mounjaro and Zepbound®, developed by Eli Lilly
- Liraglutide: Sold as Saxenda® and Victoza® (and generically), also manufactured by Novo Nordisk
Forms of GLP-1 medications and FDA approval
- Injections: The name-brand medications listed above have all been FDA approved, but only in injectable form.
- Oral tablet: There is an oral GLP-1 marketed as Rybelsus®, but it’s not FDA approved for weight loss. Some healthcare providers will prescribe Rybelsus off-label for weight loss for patients who meet eligibility.
- Oral drops: Compounding pharmacies produce oral GLP drops with the same active ingredients as the brand name GLP-1s, but they are not approved by the FDA.
- Lozenges: Like oral drops, they contain the same active ingredients as the brand name GLP-1s but are produced by compounding pharmacies and are not approved by the FDA.
While the variety of GLP-1 medications makes it easy for patients to choose which method works best for them, injections may be more effective for weight loss.[4]
How Injections Work

Subcutaneous GLP-1 medications are injected into the fat just under the skin. Most users inject into their abdomen or thigh once per week. Some GLP-1 injections come pre-filled as easy-to-use pens (like an EpiPen®), while others come as vials and separate syringes that you must measure yourself.
Because subcutaneous tissue has fewer blood vessels than muscle, the drug is absorbed gradually, which helps reduce sharp peaks and gives a smoother, more sustained effect.[5]
Injections also allow for more predictable absorption patterns than oral drugs. In addition, injections avoid many of the drug interactions commonly seen with oral medications, including ones that interfere with absorption in the gut and reduce how well the medicine works.
Most injection-based regimens follow a titration schedule to get your body accustomed to the medication and minimize nausea. That means you start at a lower dose and then gradually increase the dosage every few weeks.
Side Effects of Injections
In addition to the typical side effects of GLP-1s, such as constipation, nausea, bloating, vomiting, and diarrhea, injections have their own potential side effects.[6]
Typically, they are mild and include soreness, redness, or itchiness around the injection site. However, on rare occasions, rashes and fever can develop, which are signs of infection that must be examined by a doctor.[3]
How GLP-1 Patches Work (or Don’t)

GLP-1 patches are transdermal systems, similar in concept to nicotine or hormone patches. The patches slowly release their ingredients into your skin and are absorbed. However, at this point it is not known how much absorption actually takes place with GLP-1 patches.
What is being marketed as GLP-1 patches do not actually contain GLP-1 receptor agonists like semaglutide or tirzepatide. This is because GLP-1 receptor agonists cannot be absorbed through the skin; the molecules are too big and unstable to get through the skin barrier.
Instead, GLP-1 patches include ingredients like berberine, pomegranate, L-glutamine extract, green tea extract, or any number of other things. Since they are not regulated by the FDA, sometimes it is difficult to know exactly what you’ll be absorbing.
And while some of these ingredients may stimulate your body to produce more GLP-1s, many doctors believe the patches don’t contain these ingredients in sufficient qualities to actually have an effect.[7]
Patches are typically worn once daily for 6–8 hours, though some are marketed for overnight use.
There are no wide scale studies available to show how effective these patches are, but either due to the placebo effect, actual effectiveness of the ingredients, or biased economically motivated reasons, some people swear by them.
Head-to-Head Comparison Table
| Feature | Injections | Patches |
|---|---|---|
| Approval status | ✅ FDA approved | ❌ Not FDA approved |
| Contains actual GLP-1 receptor agonist | ✅ Yes | ❌ No |
| Dosing frequency | Weekly | Daily or varies |
| Absorption reliability | High | Variable |
| Clinical data | Extensive | Limited |
| Side effects profile | Known | Emerging |
| Cost & insurance coverage | $199+/month; sometimes covered | $15/month; cash-pay |
Efficacy: Which Delivers More Medication to Your Body?

This comes down to pharmacokinetics—how the body absorbs, distributes, and uses the drug.
With injections, blood levels of semaglutide and tirzepatide are consistent and measurable. That’s why injections were used in all the major trials to test the efficacy of GLP-1s: STEP (semaglutide), SURMOUNT (tirzepatide), and SCALE (liraglutide).
In all three trials using injections, there was proven A1C improvement for diabetes as well as weight loss, demonstrating the efficacy of injections.[8]
With patches there is no such data. The skin is a less efficient delivery route than subcutaneous fat. Factors like skin hydration, hair, friction, and temperature all affect drug penetration.
That means even if the patch contains ingredients that would actually boost your body’s GLP-1 production—debatable—your body may only absorb a fraction of those ingredients.
GLP-1 Manufacturers
Branded GLP-1 medications are manufactured by heavily regulated, internationally known pharmaceutical companies.
There are also GLP-1 medications produced by compounding pharmacies, which use tirzepatide, semaglutide, or another GLP-1 receptor agonist. According to FDA rules, compounding pharmacies are allowed to produce their GLP-1 versions when there is a shortage of the branded GLP-1s.
The FDA has declared there are no longer shortages of tirzepatide and semaglutide, but some compounding pharmacies continue to produce it, most often for telehealth clinics.
These compounding pharmacies are regulated under different standards than pharmaceutical manufacturers. Although compounding pharmacies must still follow strict safety and quality guidelines, they don’t submit their products for FDA review, and they don’t have to prove clinical efficacy.
Some are reputable, following stringent USP guidelines. Others are not, so if you choose a compounded GLP-1, make sure you know the certifications of the producing pharmacy.
GLP-1 patches are made under even murkier conditions, often with little or no oversight. Even Kind, which produces some of the most popular GLP-1 patches in the world, does not disclose its manufacturer, although it does state that it is based in China and holds “multiple industry certifications.”
Other GLP-1 patches, like those that pop up on Amazon, have absolutely no information about where they are manufactured.
Safety Considerations
GLP-1 injections have well-documented safety profiles. Doctors know what to expect, and side effects are usually manageable. A number of studies have proven their relative safety, and, of course, they were FDA approved, but that doesn’t mean there aren’t safety concerns.
For instance, Ozempic, which is technically for diabetes but often used “off label” for weight loss, faces over $2 billion in lawsuits relating to undisclosed side effects.[9]
GLP-1 patches are a complete grey area. Many times, you don’t even have the full ingredient list on hand, nor do you have any idea where they were manufactured and under what levels of quality control.Combine that with a lack of formal studies or obligation to disclose side effects, and it’s difficult to know what you may be getting into. People have reported itching, burning, and redness where they applied the patch and some have even reported ripping their skin when trying to remove the patch.[10]

The bottom line is, if you don’t know the ingredients, have no access to studies about potential side effects, and don’t know where they are manufactured, it makes it very difficult to make an informed decision on whether or not to use a GLP-1 patch.
Real-World Use: What Patients Report
You don’t have to look too hard to find evidence of the efficacy of GLP-1 injections. For starters, many clinical studies have proven they are effective treatments for weight loss, and there’s also the fact that the legitimate GLP-1 market is over $47 billion.[11]
That doesn’t mean injectable GLP-1s are miracle drugs. Many users have suffered side effects, usually related to gastrointestinal issues, and many struggle with weight management if they stop taking the medications.
However, potential side effects of branded GLP-1s are well-documented and must be disclosed according to FDA regulations.
Patients generally seem happy with their GLP-1 injections. Most complaints revolve around the side effects and price. For example, on WebMD, Zepbound is rated a 4.2.[12]

The GLP-patches on the market today are technically supplements and are therefore not subject to FDA approval. That means side effects do not have to be disclosed, and few, if any, clinical studies have been made regarding their efficacy.
What’s left is anecdotal evidence about how well they work. Not surprisingly, the reviews are mixed. You can find plenty of people who claim to have successfully lost weight, and plenty of people who claim they’re a scam.
Kind Patches, one of the largest GLP-1 patch producers in the world, has a mediocre 2.9 rating on Trustpilot and nearly equal numbers of 5-star reviews (37%) and 1-star reviews (38%).[11]

Cost & Insurance Coverage
GLP-1 injections are pricey, there’s no two ways around it. Although costs of some have gone down recently, branded GLP-1s are typically $499/month and up, if you are paying out of pocket.
You might pay only $199/month if you go with a non-FDA approved compounded GLP-1.
The good news is that many users of branded GLP-1s qualify for partial or full insurance coverage, especially if they have diabetes or a BMI over 30. Check with your insurance provider to see what type of coverage you have.
GLP-1 patches are not covered by any form of insurance. However, they are a small fraction of the cost of real GLP-1 medications. A month’s worth of GLP-1 patches can cost you $15 or less.
Convenience & Lifestyle Fit
Convenience is a matter of personal preference. What is easier for you? Injecting yourself once a week, or changing a bandaid-like patch once a day?
For those of you who aren’t needle shy, the once-a-week option is probably the better fit, but you do have to learn how to inject yourself and make sure you don’t miss a shot. For some, a daily routine is easier to sustain than a weekly one.
There’s also a lot less maintenance with the shot. The patch could fall off and need to be reapplied, particularly if you’re an active person.
Who Might Prefer Injections vs Patches?
If you truly want to harness the power of GLP-1 receptor agonists, you have to use the injections. GLP-1 patches don’t contain semaglutide, tirzepatide, or any other GLP-1 receptor agonist.
Who injections are better for:
- People who want evidence-based, FDA-approved therapy
- Those eligible for insurance reimbursement
- Patients with diabetes or cardiovascular risks
- Anyone prioritizing consistent, measurable results
Who patches may appeal to:
- People afraid of needles
- Curious biohackers who want to try supplements rather than true GLP-1s
- Those willing to experiment with their health
Expert Opinion
C. Michael White, professor of pharmacy practice at the University of Connecticut School of Pharmacy, is skeptical, to say the least:
The marketing seems to suggest that you could get with these natural products, these natural ingredients, the same effect that you can get with GLP-1 agonists, which is simply not the case. And in that way, they are being misleading to people.[13]
Other specialists agree: Stick with what’s tested, especially when managing chronic conditions or significant weight-loss goals.
Final Takeaway
If you’re serious about using GLP-1s for weight loss, injections are your only option. They’re supported by years of data, regulated by the FDA, and often covered by insurance.
GLP-1 patches do not contain any of the breakthrough GLP-1 receptor agonists that have made drugs like Wegovy and Ozempic so famous and so effective.
That doesn’t mean patches don’t work necessarily, but they are merely a collection of supplements that have been around for years, repackaged as a patch using the name GLP-1 to move product.
Sources
- Hamed, K., Alosaimi, M. N., Ali, B. A., Alghamdi, A., Alkhashi, T., Alkhaldi, S. S., Altowarqi, N. A., Alzahrani, H., Alshehri, A. M., Alkhaldi, R. K., Alqahtani, K. W., Alharbi, N. H., Alhulayfi, H. F., Sharifi, S. Y., & Alhulayfi, H. (2024). Glucagon-like peptide-1 (GLP-1) receptor agonists: Exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review. Cureus, 16(9). https://doi.org/10.7759/cureus.68390
- Montero, A., Sparks, G., Presiado, M., & Hamel, L. (2024). KFF health tracking poll May 2024: the public’s use and views of GLP-1 drugs. KFF. https://www. kff. org/health-costs/poll-finding/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs
- Cleveland Clinic. (n.d.). GLP-1 agonists. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
- Kwon, J., Thiara, D., & Watanabe, J. H. (2025). Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database. Expert Review of Endocrinology & Metabolism, 20(2), 163–168. https://doi.org/10.1080/17446651.2025.2462100
- Kim, H., Park, H., & Lee, S. J. (2017). Effective method for drug injection into subcutaneous tissue. Scientific Reports, 7(1), 1–11. https://doi.org/10.1038/s41598-017-10110-w
- Ghusn, W., & Hurtado, M. D. (2024). Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks. Obesity Pillars, 12, 100127. https://doi.org/10.1016/j.obpill.2024.100127
- Yaribeygi, H., Jamialahmadi, T., Moallem, S.A., Sahebkar, A. (2021). Boosting GLP-1 by Natural Products. In A. Sahebkar & T. Sathyapalan (Eds.), Natural Products and Human Diseases. Advances in Experimental Medicine and Biology, 1328. Springer, Cham. https://doi.org/10.1007/978-3-030-73234-9_36
- Trujillo, J. M., Nuffer, W., & Ellis, S. L. (2015). GLP-1 receptor agonists: A review of head-to-head clinical studies. Therapeutic Advances in Endocrinology and Metabolism, 6(1), 19–28. https://doi.org/10.1177/2042018814559725
- Mathur, B. (2025, August 19). From stomach paralysis to vision loss; Ozempic faces over $2 bn lawsuits. Business Standard. https://www.business-standard.com/health/ozempic-lawsuits-weight-loss-side-effects-stomach-paralysis-vision-loss-125081900853_1.html
- Trustpilot. (n.d.). Kind patches reviews. https://www.trustpilot.com/review/kindpatches.com?stars=1
- Markets and Markets. (2024, July). GLP-1 analogues market: Growth, size, share, and trends. https://www.marketsandmarkets.com/Market-Reports/glp-1-analogues-market-218746186.html#:~:text=Overview,understanding%20of%20market%20purchasing%20dynamics
- WebMD. (n.d.). User reviews for Zepbound (tirzepatide). https://reviews.webmd.com/drugs/drugreview-187794-zepbound-subcutaneous?conditionid=&sortval=1&page=2
- Grabenstein, H. (2025, September 3). In the gray world of GLP-1 supplements online, health experts urge caution. PBS News. https://www.pbs.org/newshour/health/what-to-know-before-you-buy-a-weight-loss-supplement-on-tiktok





